Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04132843 · ClinicalTrials.gov registry record · NA
Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04132843: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT04132843 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04132843, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This trial studies different magnetic resonance imaging (MRI) techniques and their ability to provide clearer pictures of lesions in patients with high grade brain lesions. An MRI is a type of imaging scan. Using different MRI techniques to produce clearer images of the brain may help researchers learn about the features of brain lesions and the effects of chemotherapy and/or radiation therapy.
Interventions
- PROCEDURE Magnetic Resonance Imaging
- DRUG Gadobutrol
- DRUG Gadobenate Dimeglumine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-01-10 |
| Est. Completion | 2022-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04132843
The ClinicalTrials.gov registry entry for NCT04132843 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT04132843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04132843 about?
NCT04132843 is a clinical study titled "Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions". This trial studies different magnetic resonance imaging (MRI) techniques and their ability to provide clearer pictures of lesions in patients with high grade brain lesions. An MRI is a type of imaging scan. Using different MRI techniques to produce clearer images of the brain may help researchers le...
What is the current status of trial NCT04132843?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2020-01-10. Estimated completion is 2022-09-01.
What interventions are being tested in trial NCT04132843?
The interventions under investigation include: Magnetic Resonance Imaging (PROCEDURE), Gadobutrol (DRUG), Gadobenate Dimeglumine (DRUG).
Who is sponsoring clinical trial NCT04132843?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.